Rafferty Asset Management, LLC
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1389426
New York, NY
Position in CRNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$216,549
-$9,916 QoQ
Shares Held
5,787
+19.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#184
of 266 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. CRNX ranks #146 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in CRNX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $216,549 | 5,787 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $226,465 | 4,865 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $257,355 | 6,179 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,610,142 | 90,756 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,425,473 | 102,131 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,154,670 | 81,257 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,979,695 | 97,450 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,024,049 | 112,169 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $10,150,701 | 216,849 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $8,691,802 | 244,289 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,880,817 | 197,741 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,490,111 | 138,186 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,067,050 | 128,708 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,948,913 | 106,498 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,481,896 | 75,453 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $834,941 | 44,769 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,715,063 | 78,135 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,480,501 | 52,112 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $579,148 | 27,513 | Shares | Sole | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||